RNA Therapeutics 2017

SMi Group’s 2017 RNA Therapeutics conference will be held February 22-23, 2017 in London, United Kingdom.

This conference intends to review clinical trial updates in RNA- based therapeutics and discuss the current regulations involved in getting drug approval.

Highlighted sessions include:

• RNA activation and its clinical application
• Collaborating to deliver macromolecules across biological barriers
• Delivery of MRNA using the Viromer system
• Therapeutic antisense oligonucleotides in oncology
• RNA therapeutics harnessing the potential of locked
• Cell entry of exosomes as a novel paradigm for therapeutic RNA delivery
• RNAI and tumor microenvironment: pre-clinical and clinical evidence
• Antisense in the fourth decade: Third generation antisense fulfilling the promise
• Interacting with the medicines regulator on RNAI therapies
• Nano-therapeutics; the best of all possible worlds?
• Intravenously injectable RNA nanomedicines as cancer vaccines: case study with RNA-lipoplexes
• Spherical nucleic acids: Structures for topical gene regulation

Please visit SMi’s RNA Therapeutics conference website for more information and registration.